Media Coverage
Riverside Partners to Score 7.4-Times Return on BioAgilytix
Riverside Partners, a Boston-based private equity firm today announced that its portfolio company, BioAgilytix, a leading provider of large molecule bioanalytical testing services, signed an agreement to be acquired by Cobepa S.A., a privately-held investment company.
![Private Equity News logo](https://www.bioagilytix.com/wp-content/uploads/2023/06/private-equity-news-logo.png)